Rhenman & Partners Asset Management’s Dynavax Technologies DVAX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-772,000	Closed	-$7.67M	–	99
2025 Q3	$7.67M	Buy	772,000 +207,000	+37%	+$2.15M	0.85%	42
2025 Q2	$5.6M	Hold	565,000	–	–	0.71%	44
2025 Q1	$7.33M	Sell	565,000 -274,131	-33%	-$3.63M	0.84%	38
2024 Q4	$10.7M	Sell	839,131 -350,869	-29%	-$4.24M	1.1%	35
2024 Q3	$13.3M	Sell	1,190,000 -42,361	-3%	-$467K	1.08%	33
2024 Q2	$13.8M	Buy	1,232,361 +75,000	+6%	+$873K	1.33%	26
2024 Q1	$14.4M	Buy	1,157,361 +357,361	+45%	+$4.66M	1.36%	27
2023 Q4	$11.2M	Buy	800,000 +100,000	+14%	+$1.39M	1.12%	33
2023 Q3	$10.3M	Hold	700,000	–	–	1.11%	35
2023 Q2	$9.04M	Sell	700,000 -25,000	-3%	-$285K	0.95%	37
2023 Q1	$7M	Sell	725,000 -58,519	-7%	-$625K	0.77%	43
2022 Q4	$8.34M	Buy	783,519 +50,000	+7%	+$581K	0.87%	45
2022 Q3	$8.4M	Sell	733,519 -66,481	-8%	-$866K	0.88%	45
2022 Q2	$10.1M	Buy	800,000 +119,324	+18%	+$1.27M	1.14%	34
2022 Q1	$7.38M	Sell	680,676 -69,324	-9%	-$842K	0.73%	50
2021 Q4	$10.7M	Hold	750,000	–	–	0.71%	51
2021 Q3	$14.4M	Hold	750,000	–	–	1.01%	42
2021 Q2	$7.39M	Sell	750,000 -36,211	-5%	-$329K	0.5%	67
2021 Q1	$7.73M	Sell	786,211 -139,323	-15%	-$1.15M	0.54%	57
2020 Q4	$4.12M	Hold	925,534	–	–	0.34%	71
2020 Q3	$4M	Hold	925,534	–	–	0.36%	68
2020 Q2	$8.21M	Sell	925,534 -74,466	-7%	-$376K	0.89%	46
2020 Q1	$3.53M	Sell	1,000,000 -80,000	-7%	-$371K	0.49%	59
2019 Q4	$6.18M	Sell	1,080,000 -154,335	-13%	-$825K	0.68%	58
2019 Q3	$4.41M	Hold	1,234,335	–	–	0.55%	59
2019 Q2	$4.92M	Buy	1,234,335 +949,335	+333%	+$5.5M	0.54%	59
2019 Q1	$2.08M	Buy	+285,000	New	+$2.79M	0.24%	71
2018 Q1	–	Sell	-242,812	Closed	-$4.54M	–	93
2017 Q4	$4.54M	Sell	242,812 -131,725	-35%	-$2.64M	0.61%	58
2017 Q3	$8.05M	Sell	374,537 -212,793	-36%	-$3.37M	1.03%	37
2017 Q2	$5.67M	Sell	587,330 -397,366	-40%	-$2.58M	0.81%	48
2017 Q1	$5.86M	Buy	984,696 +499,696	+103%	+$2.4M	0.93%	45
2016 Q4	$1.92M	Buy	485,000 +185,000	+62%	+$1.36M	0.37%	76
2016 Q3	$3.15M	Buy	300,000 +150,000	+100%	+$2.16M	0.5%	67
2016 Q2	$2.19M	Hold	150,000	–	–	0.39%	71
2016 Q1	$2.89M	Buy	150,000 +95,000	+173%	+$1.92M	0.57%	62
2015 Q4	$1.33M	Hold	55,000	–	–	0.2%	92
2015 Q3	$1.35M	Sell	55,000 -67,835	-55%	-$1.92M	0.22%	86
2015 Q2	$2.88M	Hold	122,835	–	–	0.35%	84
2015 Q1	$2.75M	Hold	122,835	–	–	0.46%	77
2014 Q4	$2.07M	Hold	122,835	–	–	0.6%	74
2014 Q3	$1.76M	Hold	122,835	–	–	0.51%	83
2014 Q2	$1.97M	Hold	122,835	–	–	0.58%	62
2014 Q1	$2.21M	Sell	122,835 -17,165	-12%	-$318K	0.66%	54
2013 Q4	$2.74M	Buy	+140,000	New	+$2.05M	1.07%	37

Other funds holding DVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rhenman & Partners Asset Management's DVAX Position: Q4 2025 in Review

Rhenman & Partners Asset Management sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 772,000 shares — an estimated $7.67M sold.

Rhenman & Partners Asset Management first reported a position in DVAX in Q4 2013 and held it in 44 quarters. The position peaked at $14.4M in Q3 2021. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

Rhenman & Partners Asset Management reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
Rhenman & Partners Asset Management sold 772,000 Dynavax Technologies shares in Q4 2025, an estimated $7.67M.
Rhenman & Partners Asset Management first reported a position in Dynavax Technologies in Q4 2013 and held it in 44 quarters.
Rhenman & Partners Asset Management's Dynavax Technologies position peaked at $14.4M in Q3 2021.
266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.